These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9237796)

  • 1. Regulation of autoimmune diabetes by interleukin 3-dependent bone marrow-derived cells in NOD mice.
    Ito A; Aoyanagi N; Maki T
    J Autoimmun; 1997 Aug; 10(4):331-8. PubMed ID: 9237796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
    Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T
    Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes.
    Li R; Perez N; Karumuthil-Melethil S; Vasu C
    Diabetes; 2007 Sep; 56(9):2251-9. PubMed ID: 17596402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
    Kaufman CL; Li H; Ildstad ST
    J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
    Mathieu C; Casteels K; Bouillon R; Waer M
    J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb.
    Chowdhury SA; Nagata M; Yamada K; Nakayama M; Chakrabarty S; Jin Z; Kotani R; Yokono K
    Kobe J Med Sci; 2002 Dec; 48(5-6):167-75. PubMed ID: 12657834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
    J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
    Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
    J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
    Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
    J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
    Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
    Balasa B; Lee J; Sarvetnick N
    Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
    Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
    Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes.
    Zaccone P; Fehérvári Z; Jones FM; Sidobre S; Kronenberg M; Dunne DW; Cooke A
    Eur J Immunol; 2003 May; 33(5):1439-49. PubMed ID: 12731071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
    Balasa B; Davies JD; Lee J; Good A; Yeung BT; Sarvetnick N
    J Immunol; 1998 Oct; 161(8):4420-7. PubMed ID: 9780221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.